Qiagen rolls out multiplex test for seasonal infections and Covid-19 in Europe
The test is capable of differentiating the influenza virus A and B, respiratory syncytial virus (RSV) and SARS-CoV-2…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Nov 20
The test is capable of differentiating the influenza virus A and B, respiratory syncytial virus (RSV) and SARS-CoV-2…
16 Nov 20
The PCR saliva test kit includes a collection device that changes the sample colour to ensure the correct…
16 Nov 20
The CE-IVD marking allows the use of the RT-PCR test to pool five sample specimens collected from people…
16 Nov 20
Lantheus' product is an AI-enabled vendor neutral platform that calculates aBSI by automatically detects hotspots in bone indicative…
16 Nov 20
BD is a global medical technology company advancing the world of health by improving medical discovery, diagnostics and…
13 Nov 20
A newly-funded endoscopic biopsy device from Israeli firm Limaca is showing early promise in improving on the diagnostic…
12 Nov 20
The technical advance featured in the whitepaper, found here, was the result of a study into the compatibility…
12 Nov 20
Developed hand-in-hand with leading healthcare facilities, Ambra's FDA cleared ProViewer and cloud PACS system enable medical groups to…
12 Nov 20
SalivaDirect is a qualitative test designed for the detection of nucleic acid from SARS-CoV-2 in saliva collected from…
11 Nov 20
BD’s new rapid antigen test has been designed to deliver results within 15 minutes, using the BD Veritor…